Eli Lilly
LLY
LLY
3,450 hedge funds and large institutions have $605B invested in Eli Lilly in 2024 Q1 according to their latest regulatory filings, with 349 funds opening new positions, 1,412 increasing their positions, 1,284 reducing their positions, and 117 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10% more repeat investments, than reductions
Existing positions increased: 1,412 | Existing positions reduced: 1,284
5% more call options, than puts
Call options by funds: $7.83B | Put options by funds: $7.46B
1.94% less ownership
Funds ownership: 83.94% → 82% (-1.9%)
Holders
3,450
Holding in Top 10
459
Calls
$7.83B
Puts
$7.46B
Top Buyers
| 1 | +$1.11B | |
| 2 | +$880M | |
| 3 | +$807M | |
| 4 |
BlackRock
New York
|
+$646M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$488M |
Top Sellers
| 1 | -$8.72B | |
| 2 | -$2.64B | |
| 3 | -$1.72B | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$864M |
| 5 |
Primecap Management
Pasadena,
California
|
-$673M |